risperidone has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 13 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 72 patients with a first episode of schizophreniform psychosis (schizophrenia spectrum disorder) with less than 2 weeks of exposure to antipsychotic medication were randomized to quetiapine or risperidone in a single-blind 12-week controlled trial." | 9.14 | Esquire trial: efficacy and adverse effects of quetiapine versus risperidone in first-episode schizophrenia. ( Craig, TK; Elanjithara, T; Gafoor, R; Landau, S; McGuire, P; Power, P, 2010) |
| "Following an earlier study in which elderly patients with schizophrenia had their typical antipsychotic medication changed to olanzapine or risperidone, the 61 patients were followed for up to a further six months to see if either treatment was superior in terms of efficacy or side effects." | 9.12 | A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration. ( Ames, D; Chiu, E; Hall, K; Halliday, G; Harrigan, S; Hassett, A; Hustig, H; MacFarlane, S; Mastwyk, M; Nagalingam, V; O'Connor, DW; Opie, J; Ritchie, CW; Snowdon, J, 2006) |
| "A total of 72 patients with a first episode of schizophreniform psychosis (schizophrenia spectrum disorder) with less than 2 weeks of exposure to antipsychotic medication were randomized to quetiapine or risperidone in a single-blind 12-week controlled trial." | 5.14 | Esquire trial: efficacy and adverse effects of quetiapine versus risperidone in first-episode schizophrenia. ( Craig, TK; Elanjithara, T; Gafoor, R; Landau, S; McGuire, P; Power, P, 2010) |
| "Following an earlier study in which elderly patients with schizophrenia had their typical antipsychotic medication changed to olanzapine or risperidone, the 61 patients were followed for up to a further six months to see if either treatment was superior in terms of efficacy or side effects." | 5.12 | A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration. ( Ames, D; Chiu, E; Hall, K; Halliday, G; Harrigan, S; Hassett, A; Hustig, H; MacFarlane, S; Mastwyk, M; Nagalingam, V; O'Connor, DW; Opie, J; Ritchie, CW; Snowdon, J, 2006) |
| ": Among 5,391 individuals with parkinsonism who died during the study period (2002-2008) and a matched comparison group of 25,937 who were still alive, individuals exposed to atypical antipsychotic drugs had a higher risk of death (unadjusted odds ratio [OR] = 2." | 1.38 | Antipsychotics and mortality in Parkinsonism. ( Anderson, GM; Fischer, H; Gill, SS; Gruneir, A; Herrmann, N; Hyson, C; Marras, C; Rochon, PA; Wang, X, 2012) |
| "A large cohort of 1528 patients with parkinsonism was analyzed, gathering data on demography, motor and non-motor characteristics, as well as the final etiologic diagnoses based on established criteria." | 1.36 | The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics. ( Munhoz, RP; Teive, HA; Werneck, LC, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Garzón, M | 3 |
| Angal, S | 3 |
| Rana, M | 3 |
| Bridel, C | 1 |
| Garibotto, V | 1 |
| Thomas Antérion, C | 1 |
| Convers, P | 1 |
| Desmales, S | 1 |
| Borg, C | 1 |
| Laurent, B | 1 |
| Bharadwaj, R | 1 |
| Grover, S | 1 |
| Chan, HY | 1 |
| Chang, CJ | 1 |
| Chiang, SC | 1 |
| Chen, JJ | 1 |
| Chen, CH | 1 |
| Sun, HJ | 1 |
| Hwu, HG | 1 |
| Lai, MS | 1 |
| Moncrieff, J | 1 |
| Cohen, D | 1 |
| Mason, JP | 1 |
| Munhoz, RP | 1 |
| Werneck, LC | 1 |
| Teive, HA | 1 |
| Gafoor, R | 1 |
| Landau, S | 1 |
| Craig, TK | 1 |
| Elanjithara, T | 1 |
| Power, P | 1 |
| McGuire, P | 1 |
| Marras, C | 1 |
| Gruneir, A | 1 |
| Wang, X | 1 |
| Fischer, H | 1 |
| Gill, SS | 1 |
| Herrmann, N | 1 |
| Anderson, GM | 1 |
| Hyson, C | 1 |
| Rochon, PA | 1 |
| Nakagawa, S | 1 |
| Koyama, T | 1 |
| Ritchie, CW | 1 |
| Chiu, E | 1 |
| Harrigan, S | 1 |
| MacFarlane, S | 1 |
| Mastwyk, M | 1 |
| Halliday, G | 1 |
| Hustig, H | 1 |
| Hall, K | 1 |
| Hassett, A | 1 |
| O'Connor, DW | 1 |
| Opie, J | 1 |
| Nagalingam, V | 1 |
| Snowdon, J | 1 |
| Ames, D | 1 |
| Czarnecki, K | 1 |
| Kumar, N | 1 |
| Josephs, KA | 1 |
| Chroni, E | 1 |
| Lekka, NP | 1 |
| Tsibri, E | 1 |
| Economou, A | 1 |
| Paschalis, C | 1 |
1 review available for risperidone and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
[Extrapyramidal syndrome].
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazep | 2003 |
3 trials available for risperidone and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Dystonia; Female; Hu | 2010 |
Esquire trial: efficacy and adverse effects of quetiapine versus risperidone in first-episode schizophrenia.
Topics: Adult; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Quetiapine Fum | 2010 |
A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Parkinsonian Disorder | 2006 |
9 other studies available for risperidone and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Topics: Antipsychotic Agents; Fatigue; Humans; Parkinsonian Disorders; Risperidone | 2022 |
Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding.
Topics: Dopamine Plasma Membrane Transport Proteins; Humans; Infarction, Middle Cerebral Artery; Middle Aged | 2015 |
An odd manifestation of the Capgras syndrome: loss of familiarity even with the sexual partner.
Topics: Aged; Amnesia; Antipsychotic Agents; Atrophy; Brain; Capgras Syndrome; Donepezil; Hallucinations; Hu | 2008 |
Parkinsonism and akathisia with quetiapine: three case reports.
Topics: Adolescent; Antipsychotic Agents; Dibenzothiazepines; Female; Hallucinations; Humans; Parkinsonian D | 2008 |
The subjective experience of taking antipsychotic medication: a content analysis of Internet data.
Topics: Adult; Affect; Akathisia, Drug-Induced; Antipsychotic Agents; Anxiety Disorders; Attitude to Health; | 2009 |
The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
Topics: Aged; Antipsychotic Agents; Cinnarizine; Cohort Studies; Diagnosis, Differential; Female; Flunarizin | 2010 |
Antipsychotics and mortality in Parkinsonism.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cohort Studies | 2012 |
Parkinsonism and tardive antecollis in frontotemporal dementia--increased sensitivity to newer antipsychotics?
Topics: Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Dystonia; Humans; Male; Middle | 2008 |
Acute, progressive akinetic-rigid syndrome induced by neuroleptics in a case of Wilson's disease.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Hepatolenticular Degeneratio | 2001 |